Prevalence & Factors Associated with Sex Trading in the Year Prior to Entering Treatment for Drug Misuse in England
BACKGROUND:
This
study estimates the past year prevalence of and factors associated with sex
trading (offering sex for money, drugs or something else) among 1796 men and
women presenting to 342 drug misuse treatment agencies in England, and
identifies service development and delivery implications.
METHODS:
Secondary
analysis of baseline data from a prospective cohort was conducted. Short
Form-12 measured mental and physical wellbeing, psychiatric diagnoses were
self-reported and the circumstances, motivation and readiness tool assessed
readiness for/pressure to enter treatment. Logistic regression models
determined associations with sex trading separately by sex. Inverse probability
population weights were calculated, utilising demographics from the National
Drug Treatment Monitoring System and agency specific data collection windows.
RESULTS:
The
estimated prevalence rate of sex trading in the past 12 months was 5.1% (15.0%
for women and 2.1% for men). For women, adjusted models identified crack use,
previous treatment and greater readiness
for treatment as independently associated
with sex trading. For men, lower mental wellbeing was independently associated and marginal effects were identified for
syringe sharing and unprotected sex.
CONCLUSIONS:
Sex
trading among drug misusers is associated with additional health risks and
specific treatment needs. Given the scale of the problem it is important that
treatment providers have the competencies to adequately address the issue and
provide accessible and appropriate services.
- 1King's College London, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, 4 Windsor Walk, London SE5 8BB, United Kingdom. Electronic address: gail.gilchrist@kcl.ac.uk.
- 2King's College London, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, 4 Windsor Walk, London SE5 8BB, United Kingdom. Electronic address: Nicola.Singleton@kcl.ac.uk.
- 3National Drug Evidence Centre, Institute of Population Health, University of Manchester, Ellen Wilkinson Building, 4th Floor, Oxford Road, Manchester M13 9PL, United Kingdom. Electronic address: M.Donmall@manchester.ac.uk.
- 4National Drug Evidence Centre, Institute of Population Health, University of Manchester, Ellen Wilkinson Building, 4th Floor, Oxford Road, Manchester M13 9PL, United Kingdom. Electronic address: Andrew.Jones@manchester.ac.uk.
- Drug Alcohol Depend. 2015 Jul 1;152:116-22. doi: 10.1016/j.drugalcdep.2015.04.017. Epub 2015 Apr 30.
No comments:
Post a Comment